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SpxA1 and SpxA2 Act Coordinately To
Fine-Tune Stress Responses and
Virulence in Streptococcus pyogenes
Gary C. Port,* Zachary T. Cusumano,* Paul R. Tumminello,* Michael G. Caparon
Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri, USA
ABSTRACT SpxA is a unique transcriptional regulator highly conserved among
members of the phylum Firmicutes that binds RNA polymerase and can act as an an-
tiactivator. Why some Firmicutes members have two highly similar SpxA paralogs is
not understood. Here, we show that the SpxA paralogs of the pathogen Streptococ-
cus pyogenes, SpxA1 and SpxA2, act coordinately to regulate virulence by ﬁne-tuning
toxin expression and stress resistance. Construction and analysis of mutants revealed
that SpxA1 mutants were defective for growth under aerobic conditions, while
SpxA2 mutants had severely attenuated responses to multiple stresses, including
thermal and oxidative stresses. SpxA1 mutants had enhanced resistance to the cat-
ionic antimicrobial molecule polymyxin B, while SpxA2 mutants were more sensi-
tive. In a murine model of soft tissue infection, a SpxA1 mutant was highly attenu-
ated. In contrast, the highly stress-sensitive SpxA2 mutant was hypervirulent,
exhibiting more extensive tissue damage and a greater bacterial burden than the
wild-type strain. SpxA1 attenuation was associated with reduced expression of sev-
eral toxins, including the SpeB cysteine protease. In contrast, SpxA2 hypervirulence
correlated with toxin overexpression and could be suppressed to wild-type levels by
deletion of speB. These data show that SpxA1 and SpxA2 have opposing roles in vir-
ulence and stress resistance, suggesting that they act coordinately to ﬁne-tune toxin
expression in response to stress. SpxA2 hypervirulence also shows that stress resis-
tance is not always essential for S. pyogenes pathogenesis in soft tissue.
IMPORTANCE For many pathogens, it is generally assumed that stress resistance is
essential for pathogenesis. For Streptococcus pyogenes, environmental stress is also
used as a signal to alter toxin expression. The amount of stress likely informs the
bacterium of the strength of the host’s defense response, allowing it to adjust its
toxin expression to produce the ideal amount of tissue damage, balancing between
too little damage, which will result in its elimination, and too much damage, which
will debilitate the host. Here we identify components of a genetic circuit involved in
stress resistance and toxin expression that has a ﬁne-tuning function in tissue dam-
age. The circuit consists of two versions of the protein SpxA that regulate transcrip-
tion and are highly similar but have opposing effects on the severity of soft tissue
damage. These results will help us understand how virulence is ﬁne-tuned in other
pathogens that have two SpxA proteins.
Low-pH environments, oxidative stress, nutritional starvation, and ﬂuctuations intemperature are a few of the many stresses encountered by both pathogenic and
environmental bacteria. To protect themselves against these stresses, bacteria employ
numerous countermeasures via both general and stress-speciﬁc mechanisms. Examples
of the former include alteration of membrane ﬂuidity and degradation of damaged or
misfolded proteins. For the latter, examples include scavengers of reactive oxygen
species, differential regulation of heat shock chaperones, and alternative catabolic
pathways (reviewed in reference 1). Since the various stresses imposed by the host’s
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defensive responses can act as markers of speciﬁc temporal stages of disease progres-
sion or host compartments, pathogens often coordinately regulate stress response
programs with virulence factor expression (2). Understanding these coregulatory net-
works can provide insight into the speciﬁc cues used to regulate of virulence factor
expression in temporal and/or tissue-speciﬁc patterns.
Because of the diversity of host tissues that it can infect and the types of diseases
that it can cause, host defensive responses challenge Streptococcus pyogenes with
numerous environmental stresses. This Gram-positive bacterium primarily infects soft
tissues of the pharynx and skin to cause diseases that include pharyngitis (strep throat)
and impetigo to more severe diseases such as necrotizing fasciitis and streptococcal
toxic shock syndrome (3). However, the bacterium can also infect the eyes, ears, lungs,
muscles, bloodstream, lymph nodes, subcutaneous tissues, and perianal and vaginal
tissues (4). The later stages of infection in the majority of these tissues are characterized
by intense inﬂammation accompanied by high fever, which can impose considerable
oxidative, thermal, and cell envelope stresses. There is considerable evidence that
S. pyogenes senses several of these stresses to regulate virulence factor expression. For
example, sublethal concentrations of host cationic antimicrobial peptides (CAPs) can
induce changes in the expression of multiple virulence genes by several mechanisms,
including recognition by a two-component transcription regulator (5) and disruption of
the ExPortal, a discrete membrane microdomain required for optimal protein secretion
and processing (6).
To gain insight into how stress sensing by the ExPortal is coupled to virulence factor
expression, we recently conducted a genetic screening to identify mutations that
confer resistance to the disruptive effects of CAPs (7). Loss of function due to mutations
in the gene encoding ClpX exhibited multiple phenotypes, including increased resis-
tance to killing by the CAP polymyxin B, enhanced resistance to ExPortal disruption,
resistance to heat stress, and decreased expression of SpeB (7), a secreted cysteine
protease important for virulence (reviewed in reference 8). ClpX is a member of a family
of AAA ATPases that interact with ends of the multimeric barrel-shaped serine
protease ClpP and are responsible for the recognition, unfolding, and translocation of
proteins into the proteolytic core (reviewed in references 9 and 10). All streptococci
encode ClpX, ClpL, ClpE, and ClpC, each of which recognizes a distinct sequence motif
on proteins destined for degradation (11). The ClpP proteolytic subunit is essential for
growth under stress conditions in a variety of Gram-positive bacteria (12–14), including
various streptococcal species (11, 15, 16).
Clp ATPases typically contribute to stress resistance by removing or refolding
damaged proteins. However, ClpX has a nonstress role in the regulation of many
complex processes in streptococci and other Gram-positive bacteria with low GC
content. In these species, mutation of ClpX and/or ClpP typically results in pleiotropic
effects, including defects in competence, sporulation, cell division, and the regulation
of certain stress-speciﬁc responses (17). These defects are often alleviated through
secondary mutation of the ClpXP substrate SpxA (suppressor of clpP and clpX) (re-
viewed in references 18 and 19). SpxA has been most thoroughly characterized in
B. subtilis, where it has been shown to act as a global transcriptional regulator through
its interaction with the  subunit of RNA polymerase (RNAP) (20). SpxA has been
proposed to function primarily as an antiactivation factor by interfering with the ability
of transcriptional activators to bind to RNAP (20). However, there is evidence that it may
also directly inﬂuence the interaction of RNAP with DNA, resulting in both positive and
negative regulation of 100 genes in B. subtilis (21, 22). Since SpxA is a ClpX substrate,
the absence of ClpXP chaperone or proteolytic activity results in a dramatic increase
in the level of SpxA. Thus, the loss of SpxA can often suppress phenotypes associated
with the loss of ClpXP (18, 19). While several Gram-positive bacterial species with low
GC content encode a single version of SpxA, all members of the family Streptococcaceae
possess two paralogs typically named SpxA1 and SpxA2 (23–25).
In this study, we examined various SpxA1 and SpxA2 mutants to further probe the
mechanism by which ClpX simultaneously regulates both stress response and virulence
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factor expression in S. pyogenes. This analysis revealed nonoverlapping roles for each of
the SpxA proteins in stress resistance, toxin expression, and pathogenesis, suggesting
that they act coordinately to ﬁne-tune these responses. Unexpectedly, SpxA2mutants
were hypervirulent despite being profoundly sensitive to thermal and oxidative
stresses, revealing that sensitivity to these stresses does not hinder the ability of
S. pyogenes to infect soft tissue.
RESULTS
SpeB regulation requires both ClpX and ClpP. ClpXmutants fail to express SpeB
protease activity and display signiﬁcantly decreased levels of the speB transcript (7). To
determine if additional Clp proteins participate in SpeB regulation and whether ClpX
acts in a ClpP-dependent or -independent manner, mutants were generated by a gene
insertion strategy in clpP, the genes for the three additional members of the Clp
chaperone family (ClpC, ClpE, and ClpL), and a regulator of the transcription of these
genes (CtsR) that are found in serotype M14 S. pyogenes HSC5 (see Table S1). CtsR is
predicted to bind to a conserved DNA sequence within the promoters of clpP, groES-
groEL, and the genes encoding all Clp chaperones, with the exception of ClpX (see
Fig. S1 in the supplemental material). Of the Clp chaperones, only the loss of ClpX was
associated with a complete loss of proteolytic activity when examined on protease
indicator plates and a 90% reduction relative to the wild type (WT) as measured by a
protease assay (Fig. 1A and B). This loss could be complemented by the expression of
ClpX from a plasmid or from an ectopic chromosomal locus (Fig. 1B). Insertional
inactivation of clpP, as well as a nonpolar mutation in clpP (ΔClpP::aad9), resulted in a
failure to detect any protease activity, similar to a SpeBmutant, a catalytically inactive
C192S allele of speB, and medium alone (Fig. 1A and B). Investigation of transcript levels
indicated that while ClpX and ClpP both affect SpeB expression over time, they do so
in different patterns. SpeB expression is subject to multiple levels of regulation (re-
viewed in reference 8), shows a strict dependence on the growth phase, and is induced
only upon entry into stationary phase (26), and its transcription is dependent on the
DNA-binding transcriptional activator RopB (27). Analysis of speB transcript levels by
real-time reverse transcription (RT)-PCR indicated that speB was expressed in the ClpX
mutant, yet its induction was delayed and transcript levels were decreased at all of the
time points investigated compared to those of the WT, including 2 h after entry into
stationary phase, when speB is maximally expressed in the WT (Fig. 1C). In contrast, the
loss of ClpP phenocopied the loss of RopB, in that speB expression was undetectable
throughout the time course (Fig. 1C). Similar differences were observed upon exami-
nation of the SpeB polypeptide in culture supernatants. Following its secretion, SpeB is
proteolytically processed via multiple cleavage events from a 40-kDa zymogen into a
28-kDa active protease. A Western blot analysis of culture supernatants indicated that
while the ClpX mutant produced less SpeB than the WT (Fig. 1D), SpeB was unde-
tectable in the absence of ClpP, similar to a SpeB mutant, in contrast to the catalyt-
ically inactive C192S SpeB mutant protein, which remains in its unprocessed 40-kDa
zymogen form (Fig. 1D).
SpxA2 negatively regulates SpeB. Like all streptococci, S. pyogenes contains two
paralogs of the gene for SpxA, whose functional loss can suppress many of the complex
phenotypes that result from a ClpX deﬁciency (reviewed in references 18 and 19). Both
Spx paralogs possess a conserved N-terminal CxxC redox-sensing domain and a con-
served glycine residue (see Fig. S2) critical for its interaction with the C-terminal domain
of the  subunit (CTD) of RNAP (20). Multiple comparisons show that S. pyogenes
SpxA1 is most similar to Spx in those bacterial species that have only a single version
of Spx (see Fig. S2). Mutants were constructed with in-frame deletions in each Spx-
encoding gene, in both the WT and ClpX backgrounds (see Table S1). Double mutants
were then tested for the ability of Spx mutations to suppress the SpeB expression
defect of a ClpXmutant. Analysis of proteolytic activity revealed that the loss of SpxA1
did not alter the ClpX-associated SpeB expression defect. In contrast, the ClpX
SpxA2 mutant not only suppressed the defective ClpX phenotype but expressed
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FIG 1 ClpXP positively regulates SpeB expression and activation. The S. pyogenes strains indicated were
tested for protease activity by spotting onto protease indicator plates (A) and by determination of
protease activity in cell-free supernatants with a ﬂuorescent casein substrate (B). For indicator plates,
images were captured after 16 h of incubation. The diameter of the zone of clearing around bacterial
growth is an indication of the level of protease activity. For supernatants, nd indicates that the level of
activity was below the limit of detection (1.0% of that of the WT). For selected strains, the relative levels
of the speB transcript over the course of growth was determined by real-time RT-PCR (C) and the
efﬁciency of processing of the proSpeB zymogen (40 kDa, closed arrowhead) into catalytically active SpeB
protease (27 kDa, open arrowhead) was determined by Western blot analysis of culture supernatants at
2 h after entry into stationary phase (D). The migration of several molecular weight standards (Std, in
kilodaltons) is shown on the left. The C192S mutant strain expresses catalytically inactive SpeB, and the
SpeB mutant strain has a deletion of speB. The data shown are representative of at least two
independent experiments and, where indicated, represent the mean and standard error of the mean
derived from duplicate determinations of samples from at least two independent experiments (**, P 
0.01; ns, not signiﬁcant).
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SpeB at levels signiﬁcantly higher than those of the WT strain (Fig. 2A). Furthermore, in
the single mutant strains, SpeB expression was signiﬁcantly reduced in the SpxA1
mutant but was similar to that in the WT in the SpxA2 mutant (Fig. 2A). Together,
these data indicate that SpxA2 acts as a negative regulator of SpeB, whose repressive
activity is antagonized by ClpX. Furthermore, since SpxA1 and SpxA2 have the opposite
effect on SpeB expression and may compete for binding to CTD, these data indicate
that they may act antagonistically. These effects were not limited to SpeB, as it was
found that the ClpX mutant also had reduced transcription of the gene encoding a
second secreted toxin, the cytolysin streptolysin O, that could be suppressed by the loss
of SpxA2 but not by the loss of SpxA1 (see Fig. S3A).
SpxA2 antagonizes RopB. Numerous regulators have been reported to affect the
expression of SpeB (8). However, transcription of speB has an absolute dependence on
the transcription activator RopB, a member of the Rgg family of DNA-binding proteins
(27). Since SpxA canonically functions as an antiactivator, we tested the hypothesis that
SpxA2 antagonizes the essential activity of RopB for activation of speB transcription.
This hypothesis predicts that SpxA2 and RopB are in competition for binding to RNAP
and that SpxA2 inhibits the ability of RopB to recruit RNAP to the speB promoter. This
FIG 2 SpxA2 negatively regulates SpeB via RopB. Protease activity in cell-free culture supernatants was
determined as described for Fig. 1 in various ClpX and SpxA mutants (A) and in the strains indicated
overexpressing RopB (B). For the latter, RopB was overexpressed from a plasmid (pRopB) for comparison
to the strain with no plasmid (none) or the vector alone (pVector). The abbreviation nd indicates that
activity was below the limit of detection (1.0% relative to the WT). The data shown are the means and
the standard errors of the means derived from duplicate determinations of samples from at least two
independent experiments (*, P  0.05; **, P  0.01; ns, not signiﬁcant).
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model predicts that the level of SpeB expression will be sensitive to the ratio of the two
regulators. To test this, ropB was overexpressed from an ectopic promoter on a
multicopy plasmid, which complemented a RopB mutant to produce signiﬁcantly
more SpeB than the WT, while the activity of the RopB mutant alone or with the
empty vector was similar to that of uninoculated medium (Fig. 2B). Consistent with this
hypothesis, overexpression of ropB in the ClpXmutant suppressed its SpeB expression
defect, resulting in overexpression of SpeB similar to that of the complemented RopB
mutant (Fig. 2B). Also consistent was the ﬁnding that ectopic overexpression of SpxA2
in the WT resulted in repression of SpeB expression (see Fig. S3B).
ClpXP regulates multiple stress resistances via SpxA2. SpxA has been shown in
other organisms to regulate stress responses via ClpXP (17), and we have reported that
the ClpX mutant displays greater resistance to polymyxin B (PBr) and heat stress than
the WT (7) (also see Fig. S4). To expand this analysis, the various Clp, Spx, and regulatory
mutants were tested for the ability to grow under a variety of stress conditions. Only
the ClpX mutant displayed increased PBr (Fig. 3A) and heat resistance (Fig. 3B), and
unlike SpeB regulation (Fig. 1A), neither of these phenotypes required ClpP (Fig. 3). For
PBr, SpxA1 and SpxA2 had an antagonistic relationship. The SpxA1 mutant was more
resistant than the WT, while the SpxA2mutant was more sensitive (Fig. 4A). The effect
of the SpxA2mutation on stress sensitivity was dominant when tested in combination
with ClpX and SpxA1 mutations (Fig. 4A), and SpxA2 also had a predominant role in
thermal tolerance, as SpxA2mutants had a lower maximum growth temperature both
individually and when tested in combination with SpxA1 mutations (Fig. 4B). Although
the loss of SpxA1 had no effect, the loss of both SpxA1 and SpxA2 was combinatorial,
FIG 3 ClpX, but not other Clp mutants, displays PBr and heat resistance. The strains indicated were
monitored for PBr (A), and the Tmax was determined (B). PBr is reported as the efﬁciency of plating on
medium lacking or containing polymyxin B (40 g ml1) and was calculated as log10 (CFUPB/CFUunmod).
The Tmax was determined by incubating strains over a 0.1°C stepwise gradient and scoring them for
growth after 24 h. The data shown represent means and standard errors of the means derived from
duplicate determinations of samples from at least three independent experiments (*, P  0.05; **, P 
0.01; ns, not signiﬁcant).
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resulting in even greater thermal sensitivity (Fig. 4B). Considering that SpxA mutants in
other bacterial species display differential resistance to oxidative stress (22, 28, 29), the
S. pyogenes mutants were challenged by the addition of oxidizing agents to the
medium. While the ClpX mutant did not display increased resistance, all mutants
lacking SpxA2 had signiﬁcantly lower MICs of both paraquat (Fig. 4C) and diamide
(Fig. 4D). Together, these data indicate that stress resistance is mediated primarily via
SpxA2 and suggest that the increase in stress resistance displayed by the loss of ClpX
results from increased levels of SpxA2.
SpxA1 and SpxA2 are required for aerobic growth. Under anaerobic conditions,
all mutants had growth yields comparable to those of the WT in liquid medium (Fig. 5A)
and formed colonies on solid medium (Fig. 5B) equivalent to those of the WT. However,
under aerobic conditions, the loss of either SpxA1 or SpxA2 alone resulted in a 40 to
60% decrease in the ﬁnal growth yields and a combination of the two mutations
resulted in a 90% reduction of the yield in liquid medium (Fig. 5A) and an inability to
form colonies at all on solid medium (Fig. 5C). In contrast, the ClpX mutant exhibited
robust growth under all conditions and suppressed the SpxA1 growth defect on solid
medium (Fig. 5A to C). A series of cultures were then shifted between conditions. When
liquid cultures of the various SpxA mutants were grown under anaerobic conditions for
24 h and subsequently exposed to aerobic conditions, no decrease in the CFU count
was observed (see Fig. S4A and B). However, when cultures grown under aerobic
conditions were then exposed to anaerobic conditions, the CFU count increased over
the course of an additional 24 h to obtain ﬁnal densities similar to those of the WT (see
Fig. S4C and D). These data suggest that the inhibition of aerobic growth mediated by
FIG 4 ClpX negatively regulates multiple stress resistances via SpxA2. The strains indicated were monitored for PBr
(A), for the Tmax (B), and for resistance to the oxidizing agents paraquat (C) and diamide (D). PBr was determined
as efﬁciency of plating on medium lacking or containing polymyxin B (40 g ml1) and calculated as log10
(CFUPB/CFUunmod). The Tmax was measured by incubating strains over a 0.1°C stepwise gradient and scoring them
for growth after 24 h. Resistance to paraquat and diamide was calculated as the lowest concentration of reagent
that resulted in a 10% ﬁnal growth yield of the treated versus untreated strain. The data shown are the means
and standard errors of the means derived from duplicate determinations from at least three independent
experiments (*, P  0.05; **, P  0.01; ns, not signiﬁcant).
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loss of SpxA1 or SpxA2 is likely to occur via a bacteriostatic rather than bactericidal
mechanism.
Loss of SpxA2 results in hypervirulence. Since ClpX modulates virulence gene
expression via SpxA1 and SpxA2, we assessed the pathogenic potential of these
mutants during infection. In the murine subcutaneous infection model, S. pyogenes
HSC5 (WT) forms a localized lesion characterized by ulceration and the formation of an
eschar that expands in size to reach a peak area by day 3 postinfection (4). Loss of ClpX
or SpxA1 resulted in a signiﬁcant decrease in virulence, as measured by both smaller
lesion sizes (Fig. 6A) and tissue CFU burdens (Fig. 6B). In contrast, loss of SpxA2 resulted
in hypervirulence, with signiﬁcantly larger lesions and bacterial burdens (Fig. 6A and B),
and rapidly developing lesions that were signiﬁcantly larger as early as 24 h postin-
fection (see Fig. S5). Loss of SpxA2, but not that of SpxA1, could suppress the virulence
defect of the ClpXmutant and restore virulence to WT levels (Fig. 6A and B). However,
mutants lacking both SpxA1 and SpxA2 were attenuated (Fig. 6A and B). Examination
of SpeB expression and maturation by a Western blot analysis of tissue homogenates
normalized for tissue burden revealed that production of the active form of SpeB in vivo
paralleled that observed in C medium. Relative to the WT, the ClpX and SpxA1
mutants produced primarily unprocessed and inactive SpeB, the SpxA2 mutant
FIG 5 SpxA1 is required for aerobic growth. The strains indicated were tested for growth under
anaerobic (minus O2) or aerobic (plus O2) conditions in liquid medium (A) and for the ability to form
colonies on solid medium (B and C). For liquid medium, growth was measured by determining the OD600
following 24 h of incubation. For solid medium, overnight liquid cultures were serially diluted (Dilution)
and then plated under aerobic or anaerobic conditions for examination after 24 h. The data shown are
the means and standard errors of the means derived from duplicate determinations of at least three
independent experiments or are images representative of at least three independent experiments.
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produced high levels of fully processed SpeB, and the loss of SpxA2, but not that of
SpxA1, suppressed the ClpX defect (Fig. 6C). While there was not a strict correlation
between SpeB expression and virulence across the mutant panel, high SpeB expression
was a prominent phenotype associated with the loss of SpxA2. Therefore, we tested
whether SpeB contributed to SpxA2 hypervirulence. Deletion of speB alone resulted in
attenuation relative to the WT (Fig. 6D and E). Subsequent deletion of speB in a SpxA2
background attenuated hypervirulence to levels at or just below those of the WT
(Fig. 6D and E). Taken together, these data show that SpxA1 and SpxA2 have opposing
effects on virulence, that SpeB contributes to SpxA2 hypervirulence, and that the loss
of SpxA1 is dominant over the loss of SpxA2 since all mutants that lack both genes are
attenuated despite elevated SpeB expression.
FIG 6 SpxA1 mutants are attenuated, and SpxA2 mutants are hypervirulent. Hairless SKH1 mice were
infected subcutaneously with 107 CFU of the strains indicated. The areas of the resulting ulcers at day 3
postinfection are shown (A, D). Each symbol represents an individual animal. A symbol overlaid with a
horizontal line indicates a mouse that succumbed to infection prior to day 3. Values in parentheses
adjacent to symbols placed off scale indicate actual lesion areas. Tissues were then harvested and
processed to determine CFU counts (B, E) and levels of SpeB (C), which were determined by immuno-
blotting of samples normalized for bacterial burden. On the left, the open and closed arrowheads
indicate processed and unprocessed SpeB, respectively, and the migration of several molecular weight
standards (in kilodaltons) is shown. The data are pooled from at least two independent experiments, and
the mean is indicated by a bar (*, P 0.05; **, P 0.01; ***, P 0.001; ns, not signiﬁcant) or are an image
representative of three independent experiments.
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We previously identiﬁed ClpX as a regulator of PBr and ExPortal integrity in serotype
M14 S. pyogenes HSC5 (7). In the present study, we showed that ClpX mediates PBr via
SpxA2, which also regulates multiple stress resistances and toxin expression. SpxA1 and
SpxA2 have opposing effects on virulence, with SpxA1 acting as a positive regulator
and SpxA2 acting as a negative regulator whose absence results in hypervirulence,
suggesting that these two proteins act coordinately to ﬁne-tune virulence in response
to various stresses. Remarkably, the SpxA2 mutant was hypervirulent despite its
exquisite sensitivity to stress, suggesting that stress resistance is not always essential for
the ability of S. pyogenes to infect and damage soft tissue.
In many other Gram-positive bacterial species, the ClpXP proteasome regulates the
stability of multiple proteins, including the paralogous SpxA family members that
function as antiactivators to occlude the interaction of various transcriptional regulators
with RNAP. Numerous studies have shown that mutation of SpxA can suppress many
phenotypes resulting from the loss of ClpX that arise from reduced turnover of SpxA’s
regulatory activities (reviewed in references 18 and 19). What is not understood is why
S. pyogenes and other streptococcal species have two SpxA family members. Analysis
across multiple streptococcal species has revealed that the loss of either SpxA1 or
SpxA2 is tolerated, as is the simultaneous loss of both paralogs (23, 29), although
exceptions have been noted (24). While both are typically involved in stress responses,
the SpxA1 and SpxA2 regulons may be nonoverlapping. For example, the loss of SpxA1
is often (23, 28–31), but not always (24), associated with increased sensitivity to
oxidative stress, while the loss of SpxA2 can be pleiotropic, resulting in growth defects
and sensitivities to multiple stresses, with phenotypes ranging from mild (29) to severe
(23, 24). Taken together, these observations indicate that SpxA1 and SpxA2 are nonre-
dundant and likely regulate different sets of genes.
The analysis of the S. pyogenes SpxA mutants presented here supports this model.
With regard to stress, the SpxA mutants had distinct phenotypes; the SpxA1 mutant
lost the ability to grow aerobically, while the SpxA2 mutant was sensitive to oxidative
stress. These two phenotypes are not necessarily identical and can involve different
types of genes. Resisting oxidative stress requires gene products that can counteract
the damage caused by oxidation or can directly detoxify the toxic products resulting
from the reduction of molecular oxygen that can be generated by various metabolic or
host defense pathways. These include various peroxidases, superoxide dismutases,
metal transporters, and DNA repair enzymes (32). The ability to grow under aerobic
versus anaerobic conditions also involves enzymes that require molecular oxygen as a
cofactor or whose activity is modulated by oxygen. Examples for S. pyogenes include
NADH oxidase, lactate oxidase, and pyruvate-formate lyase (33). With regard to viru-
lence, the SpxA mutants also had distinct phenotypes, as SpxA1 mutants were
attenuated while SpxA2 mutants were hypervirulent. Associated with hypervirulence
was overexpression of the SpeB cysteine protease, which can enhance virulence by a
number of mechanisms (34). The observation that SpxA2 was also a negative regulator
of the secreted SLO cytolysin suggests that SpxA2 may have a more extensive role in
the regulation of secreted toxins whose dysregulation may contribute to the hyper-
virulence phenotype of the SpxA2mutant. Finally, analysis of SpxA1 SpxA2 double
mutants also supports a role for the regulation of distinct gene subsets, as this mutant
had properties different from those of either single mutant. For example, SpxA1
attenuation was dominant over SpxA2 hypervirulence even though the double
mutant exhibited the SpeB hyperexpression phenotype of SpxA2.
In addition to regulation of distinct gene subsets, the ﬁnding that SpxA1 and SpxA2
have opposing effects on infection in soft tissue suggests that they act coordinately to
regulate virulence. Both paralogs are highly homologous and share a conserved glycine
residue (see Fig. S2) that has been shown to be important for binding to CTD of RNAP
(20). This suggests a ﬁne-tuning mechanism involving competition between SpxA1 and
SpxA2 for binding to CTD. In this model, the loading of a speciﬁc SpxA paralog into
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RNAP will alter how subsets of virulence gene transcription regulators interact with
RNAP. Furthermore, the two paralogs will act antagonistically because the presence of
one will exclude the other from binding to RNAP. For SpeB, SpxA2 acts in a negative
fashion, suggesting that it blocks the ability of RopB, a member of the Rgg family of
DNA-binding proteins (27), to recruit RNAP to the speB promoter (antiactivation, Fig. 7).
In contrast, RopB can likely recruit the SpxA1-RNAP complex to activate speB transcrip-
tion (activation, Fig. 7). Adaptation results from input into the network that alters the
steady state by changing the relative concentrations of the active form of any of the
components through differential changes in the expression of component genes,
through modiﬁcations of individual components that alter binding activity, or through
differential modulation of ClpXP-mediated turnover of SpxA1 versus SpxA2 (degrada-
tion, Fig. 7). This model explains how the loss of ClpX results in repression of speB
transcription (by overaccumulation of SpxA2) that can be suppressed by overexpres-
sion of ropB or by the subsequent loss of SpxA2. Reﬁnement of this model will require
uncovering of the molecular details of the various binding interactions and the regu-
latory inputs that modulate the steady state in response to speciﬁc stimuli.
SpxA2 was also involved in the regulation of PBr, as higher levels of SpxA2 in the
ClpX mutant resulted in PBr, subsequent loss of SpxA2 suppressed PBr in a double
mutant, and a single SpxA2 mutant became more polymyxin B sensitive than the WT.
The single SpxA2 mutant also became sensitive to numerous other stresses that are
thought to be characteristic of the in vivo environment. Remarkably, the highly stress-
sensitive SpxA2 mutant was hypervirulent as deﬁned by more extensive tissue
damage and an ability to achieve a greater tissue burden of bacteria than the WT. In
this regard, it should be noted that the SpxA1 mutant, while attenuated versus the
WT, was still able to cause tissue damage and grow in soft tissue, despite its inability
to grow aerobically. Given the intensity of the host’s inﬂammatory response to S. pyo-
genes, it is highly unlikely that these stresses are missing in vivo, raising the interesting
question of how the stress-sensitive SpxA mutants can proliferate. Infection by S. pyo-
genes can result in extensive remodeling of the surrounding soft tissue environment (4),
suggesting that these alterations create a protective niche that can insulate the bacteria
from excessive stress. In this case, it would be predicted that the SpxA2 mutant will
be attenuated in models of disseminated infection that do not involve extensive
remodeling. Regardless of the mechanism, these data do show that sensitivity to stress
in vitro is not necessarily predictive of a loss of virulence in vivo. To the best of our
knowledge, this is the ﬁrst example of an SpxAmutant that is hypervirulent, as SpxA
FIG 7 Model of regulation of SpeB. The data presented here and the known properties of SpxA1 and
SpxA2 are consistent with a model of SpeB regulation in which SpxA1 and SpxA2 are in competition for
binding to the C-terminal domain of the  subunit (CTD) of RNAP (which also consists of the subunits
, =, and ). Bound SpxA2 inhibits the ability of RopB, an essential activator of speB transcription, from
recruiting RNAP to the speB promoter (antiactivation). In contrast, RopB can recruit RNAP when CTD is
occupied by SpxA1 (activation), leading to expression of speB (shown by the red arrow at 1). Turnover
of SpxA1 and SpxA2 (shown by the dashed line) is via the ClpXP proteasome (degradation). Gateways for
regulatory input to change the steady state are numerous and may involve modulation of the relative
concentrations of SpxA1 and SpxA2 or differential modiﬁcation of their binding afﬁnities for CTD and
ClpX. The question mark indicates that it has not been established whether SpxA1 interacts directly with
RopB or that its positive inﬂuence is derived solely from its ability to displace SpxA2 from CTD.
Regardless, the antagonistic activities of SpxA1 and SpxA2 allow the interrogation of multiple regulatory
inputs for ﬁne-tuning of SpeB expression.
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mutants of S. mutans (29), S. sanguinis (23), and Enterococcus faecalis (28) have been
shown to be attenuated in various animal models.
In summary, the data presented in this report show that SpxA1 and SpxA2 work
antagonistically to regulate S. pyogenes virulence. The fact that the two proteins likely
compete for occupancy on RNAP suggests that they act coordinately to ﬁne-tune
virulence in concert with various mechanisms of signal transduction, including the
ExPortal and regulated proteolysis via ClpXP, to bind to RNAP and regulate the
expression of different subsets of the S. pyogenes transcriptome. In further work, it will
be important to test whether SpxA2 mutation can result in hypervirulence in diverse
S. pyogenes strains. In this regard, a genome-wide transposon sequencing analysis of
ﬁtness during in vitro culture has shown that transposon insertion in SpxA1 had no
effect on ﬁtness in an M49 strain and an M1T1 isolate that has been associated with
more virulent infections (35). In contrast, insertion in SpxA2 did not affect ﬁtness in the
M49 strain but did affect ﬁtness in the M1T1 strain (35). This suggests that heteroge-
neity in the SpxA signaling network exists. Further characterization of these SpxA
networks will provide insight into how stress is interrogated by S. pyogenes for time-
and compartment-speciﬁc regulation of virulence factor expression.
MATERIALS AND METHODS
Strains, media, and growth conditions. Routine molecular cloning and plasmid propagation used
Escherichia coli DH5, which was cultured in Luria-Bertani medium at 37°C. Experiments with S. pyogenes
used strain HSC5 (36, 37) and mutant derivatives of this strain listed in Table S1. Media and culture
conditions for anaerobic growth have been described in detail elsewhere (7). When appropriate,
antibiotics were added at the following concentrations: erythromycin, 1 g ml1 for S. pyogenes and
500 g ml1 for E. coli; kanamycin, 500 g ml1 for S. pyogenes and 50 g ml1 for E. coli.
DNA techniques. Plasmid DNA was isolated via standard techniques and used to transform S. pyo-
genes or E. coli as previously described (38). In-frame deletion mutations in chromosomal loci were
generated by standard methods with the temperature-sensitive shuttle vectors pJRS233 (39) and
pGCP213 (40) to construct the mutagenic plasmids listed in Table S2. Each deletion allele was generated
by PCR with oligonucleotide primers (IDT, Coralville, IA) listed in Table S3 by overlap extension PCR (41).
Selected mutants were constructed by an integration strategy (7) with the suicide vector pSPC18 (42) to
generate the integrational plasmids described in Table S2. Modiﬁed alleles were inserted directly into
plasmids at the M13F and M13R universal primer-binding sites by the overlap extension PCR cloning
method described in detail elsewhere (43). Complementation plasmids were generated with the shuttle
vector pABG5 (44) to insert open reading frames along with upstream ribosome-binding sites down-
stream of the rofA promoter by standard techniques as previously described (45). For ectopic chromo-
somal complementation, clpX was inserted into the chromosome directly downstream of guaB, gener-
ating a polycistron driven by the guaB promoter (see Text S1 for details). The ﬁdelity of all molecular
constructs and mutated chromosomal loci was conﬁrmed by PCR and determination of DNA sequences
(Genewiz, South Plainﬁeld, NJ) with appropriate primers. Selected mutants were subjected to whole-
genome sequencing and independently rederived to rule out the contributions of any adventitious
mutations to the phenotypes reported.
Generation of SpxA2 deletion mutants. SpxA1 deletion mutants and deletion of SpxA2 in a ClpX
background were readily obtainable; however, it was not possible to directly obtain certain SpxA2
deletion mutants. An alternative approach to restore a WT copy of clpX into the original genomic locus
in ClpX SpxA2 and ClpX SpxA1 SpxA2 mutants succeeded in generating the SpxA2 and SpxA1
SpxA2 mutants, respectively (see Table S1). These mutants had growth defects (Table S4), which likely
complicated the recovery of mutants by the original strategy.
Analysis of SpeB expression. The ability of various strains to express active SpeB protease activity
was assessed on protease indicator plates (solidiﬁed C medium supplemented with 2% milk) (27) by
plating 10-fold serial dilutions and examining the resulting zones of clearance following 16 h of
incubation (7) or in culture supernatants with a ﬂuorescein isothiocyanate-casein cleavage assay as
previously described (27), with minor modiﬁcations to adapt to a 96-well format (Text S1 for details). The
ability to secrete and process the SpeB zymogen was assessed by Western blotting analyses of culture
supernatants with an anti-SpeB rabbit serum (catalog number ab53403; Abcam, Inc., Cambridge, MA) as
previously described (7). Samples were normalized to the culture optical density at 600 nm (OD600) at the
time of harvest. The data presented are representative of at least three independent experiments.
Analysis of transcripts. The transcript abundance of selected genes was analyzed by real-time
RT-PCR as previously described (7). Brieﬂy, overnight cultures were diluted 1:25 or 1:10 in fresh C medium
and RNA extracted from samples harvested at mid-logarithmic phase (50% of ﬁnal OD600), late logarith-
mic phase (75% of ﬁnal OD600), stationary phase (100% of ﬁnal OD600), or 2 h after stationary phase onset
with a commercially available kit in accordance with the manufacturer’s instructions (Direct-Zol RNA
MiniPrep, catalog number R2052; Zymo Research, Irvine, CA), with the following minor modiﬁcations. A
10-ml culture volume was subjected to centrifugation at 6,000  g for 5 min, and the cell pellet was
frozen at80°C. The cell pellet was then thawed, resuspended in 700 l of Trizol, and subjected to bead
beating with a FastPrep-24 homogenizer (MP Biomedicals, Santa Ana, CA) for 2 pulses at 6.5 m/s for 45 s,
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separated by a 5-min resting period, at 4°C. Lysates were subjected to centrifugation at 500  g for 30 s,
mixed with 100% ethanol, and loaded into RNA capture columns as directed by the manufacturer.
Selected genes were analyzed by real-time RT-PCR with the oligonucleotide primers listed in Table S3.
Relative speB transcript levels are displayed as ΔCT, normalized to recA for each strain and time point,
while relative transcript levels of slo are displayed as –ΔΔCT, normalized to recA and relative to the WT
as previously described (7). The data shown are the mean and the standard error of the mean derived
from duplicate determinations of samples from at least two independent experiments.
Determination of PBr, growth rate, and maximum growth temperature. PBr was quantitated by
an efﬁciency-of-plating assay on polymyxin B-supplemented medium as previously described (7). Growth
rates and yields were determined by monitoring growth in C medium and calculated as described
previously (7). The maximum growth temperature was determined with C medium and incubating
multiple 250-l cultures of each strain indicated in a thermocycler (Mastercycler pro S; Eppendorf,
Hauppauge, NY) set at a constant temperature with a 1°C gradient spread over 12 adjacent wells. The
maximum growth temperature (Tmax) was deﬁned as the highest temperature with visible growth where
at least three sequential wells at lower temperatures had visible growth and three sequential wells at
higher temperatures had no visible growth. The data presented are the mean and standard error derived
from at least ﬁve independent experiments.
Aerobic growth. The ability of strains to grow aerobically was tested as follows. Strains were cultured
overnight in 10 ml of C medium in sealed culture tubes at 37°C under static conditions. Cultures were
then back diluted 1:1,000 into 5 ml of fresh medium in loosely capped glass test tubes (18 by 150 mm)
and cultured at 37°C either in a roller drum spinning at 86 rpm (aerobic) or in a sealed jar with a
commercial gas generator (anaerobic; catalog number B260001; Fisher, Waltham, MA). A 500-l sample
was removed every 24 h over the course of 2 days to measure the OD600 and determine the number of
CFU ml1 by spotting serial dilutions onto solid medium that was incubated anaerobically. The data
presented are the mean and standard error derived from at least three independent experiments.
Oxidative stress resistance. The oxidizing agents diamide (catalog number D3648; Sigma, St. Louis,
MO) and paraquat (methyl viologen, catalog number 856177; Sigma) were added to C medium as
follows. Diamide was added to achieve ﬁnal concentrations ranging from 0 to 275 M in 25 M stepwise
increments. Paraquat was added in either a small-dose series (0 to 1 mM in 0.1 mM stepwise increments)
or a large dose series (0 to 10 mM in 1 mM stepwise increments). For analysis, aliquots of supplemented
test medium (200 l) were added to individual wells of a 96-well plate (catalog number 3370; Corning,
Corning, NY) and inoculated from frozen glycerol stocks. Plates were covered with loosely ﬁtting lids and
wrapped with Saran wrap to avoid evaporation and incubated for 24 h at 37°C under constant rotation
at 200 rpm. Growth yield was monitored by measuring the OD600 with a Tecan Inﬁnite M200 Pro plate
reader. The MIC was deﬁned as the lowest concentration of oxidizing agent that resulted in10% of the
ﬁnal growth yield relative to control medium lacking oxidizing agent (OD600-test/OD600-control  10%).
The data presented are the mean and standard error from at least ﬁve independent experiments.
Subcutaneous ulcer model of infection. Infection of mice followed a well-established protocol.
Brieﬂy, 6- to 8-week-old female SKH1 mice (Charles River Laboratories, Inc., Wilmington, MA) were
injected with approximately 107 CFU of the bacterial strains indicated by a previously described method
(46, 47). Following infection, the resulting ulcers were examined over the course of 3 days and
documented by digital photography. The areas of the resulting irregular lesions were calculated from
captured images with ImageJ (http://imagej.nih.gov/ij/). To quantify bacterial CFU counts at the lesion
sites, mice were sacriﬁced at 72 h postinfection and the infected mouse tissue samples were excised and
placed into 2-ml screw-cap tubes (catalogue number 02-707-355; Fisher) along with two 5-mm stainless
steel beads (catalog number 69989; Qiagen, Valencia, CA) and 1 ml of pH 11 water (48). Tissue samples
were homogenized with a FastPrep-24 homogenizer (MP Biomedical) at speed 6.0 m/s for two bursts of
45 s each, separated by a 5-min resting period, at 4°C. Aliquots were then serially diluted and spotted
onto solid medium, which was incubated at 37°C under anaerobic conditions. To quantify SpeB
expression, homogenized samples were subjected to centrifugation at 500  g for 5 min at 4°C, and
200 l of supernatant was collected and then subjected to an additional round of centrifugation at
6,000  g for 5 min at 4°C. Aliquots were normalized to bacterial CFU counts and assessed by
Western blot analysis (see above). The data presented are pooled from two independent experi-
ments with 10 mice per experimental group.
Ethics statement. This study was carried out in accordance with the Public Health Service Policy on
Humane Care and Use of Laboratory Animals and AAALAC accreditation guidelines. The protocols were
approved by Washington University in St. Louis’ Animal Studies Committee (Animal Welfare Assurance
number A-3381-01 and protocol number 20140061).
Statistical analyses. For in vitro assays, differences between mean values were tested for signiﬁcance
with the Dunnett test. Differences between WT and mutant strains in mouse lesion size and CFU counts
were tested for signiﬁcance with the Mann-Whitney test. Test statistics were calculated with the InStat
module of GraphPad (version 3.06; GraphPad Software, Inc., La Jolla, CA). For all tests, the null hypothesis
was rejected for P values of 0.05.
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